000 | 01577 a2200469 4500 | ||
---|---|---|---|
005 | 20250513161157.0 | ||
264 | 0 | _c19990211 | |
008 | 199902s 0 0 eng d | ||
022 | _a0250-7005 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aDenardo, S J | |
245 | 0 | 0 |
_aSynergistic therapy of breast cancer with Y-90-chimeric L6 and paclitaxel in the xenografted mouse model: development of a clinical protocol. _h[electronic resource] |
260 |
_bAnticancer research _c |
||
300 |
_a4011-8 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S. | ||
650 | 0 | 4 |
_aAdenocarcinoma _xdrug therapy |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAntineoplastic Agents, Phytogenic _xtherapeutic use |
650 | 0 | 4 |
_aBreast Neoplasms _xdrug therapy |
650 | 0 | 4 | _aCombined Modality Therapy |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aHeterocyclic Compounds _xpharmacokinetics |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMice |
650 | 0 | 4 | _aMice, Nude |
650 | 0 | 4 |
_aOligopeptides _xpharmacokinetics |
650 | 0 | 4 |
_aPaclitaxel _xtherapeutic use |
650 | 0 | 4 | _aRadioimmunotherapy |
650 | 0 | 4 | _aTime Factors |
650 | 0 | 4 | _aTransplantation, Heterologous |
650 | 0 | 4 | _aTumor Cells, Cultured |
650 | 0 | 4 |
_aYttrium _xpharmacokinetics |
700 | 1 | _aRichman, C M | |
700 | 1 | _aKukis, D L | |
700 | 1 | _aShen, S | |
700 | 1 | _aLamborn, K R | |
700 | 1 | _aMiers, L A | |
700 | 1 | _aKroger, L A | |
700 | 1 | _aPerez, E A | |
700 | 1 | _aDenardo, G L | |
773 | 0 |
_tAnticancer research _gvol. 18 _gno. 6A _gp. 4011-8 |
|
999 |
_c9853196 _d9853196 |